Home Antibody All anti-IL33 antibodies
Also for IL33 (NM_033439)
|IL-33 antibody was raised against a 19 amino acid peptide from near the amino terminus of human IL-33.|
||ELISA, WB: 1 - 2 ug/ml, IF: 20 ug/ml
|PBS containing 0.02% sodium azide.|
|Affinity chromatography purified via peptide column
|Homo sapiens interleukin 33 (IL33), transcript variant 1|
|C9orf26; DVS27; IL1F11; NF-HEV; NFEHEV|
Entrez Gene 90865 Human
|Interleukin-33 (IL-33) is a recently identified member of the IL-1 family of cytokines whose other members include IL-1a/b, IL-1Ra and IL-18. Its receptor has been shown to be ST2, an IL-1 receptor family member that also acts as a negative regulator of TLR-IL-1R signaling and IL-1R accessory protein (IL-1RAcP). Receptor binding of IL-33 activates NF-kappaB and MAP kinases and induces the expression of TH2-associated cytokines such as IL-4, IL-5 and IL-6. Prolonged IL-33 treatment of mice led to the development of eosinophilia, splenomegaly, and severe pathological changes in mucosal organs such as lungs, esophagus and small intestine. Recent experiments have shown that IL-33 can also co-localize with heterochromatin and possesses transcriptional repressor activities, indicating that IL-33 may function as both a proinflammatory cytokine and an intracellular nuclear factor with transcriptional regulatory properties. Despite its predicted molecular weight, IL-33 will often run at higher molecular weight in SDS-PAGE.|
|Secreted Protein Cytosolic DNA-sensing pathway|
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of IL-33 in human lymph node tissue lysate with IL-33 antibody at (A) 1 and (B) 2 ug/mL.
Immunofluorescence of IL-33 in human lymph node tissue with IL-33 antibody at 20 ug/mL.